Ae. Rigamonti et al., Nitric oxide modulation of the growth hormone-releasing activity of Hexarelin in young and old dogs, METABOLISM, 48(2), 1999, pp. 176-182
The growth hormone (GH)-releasing activity of Hexarelin, a potent GH-releas
ing peptide (GHRP) analog, was evaluated in eight young (aged 1 to 6 years)
and five old (10 to 16 years) beagle dogs pretreated with erythrityl tetra
nitrate, a liposoluble nitric oxide (NO) donor, and/or indomethacin, an inh
ibitor of cyclooxygenase enzymes, and N-nitro-L- or N-nitro-D-arginine meth
ylester (L-NAME and D-NAME), active and inactive NO synthase (NOS) inhibito
rs, respectively, Erythrityl tetranitrate (0.3 mg . kg(-1) oral [PO]) strik
ingly potentiated Hexarelin-stimulated GH secretion (31.25 mu g . kg(-1) in
travenous [IV]) in both young (area under the time-concentration curve at 0
to 90 minutes AUC(0.90)] 878.50 +/- 267.02 v 1,994.04 +/- 434.20 ng . mL(-
1) . h, P < .01) and aged animals (314.82 +/- 117.11 v 1,314.12 +/- 484.75
ng . mL(-1) . h, P < .01). The NO donor alone did not modify baseline GH le
vels in either young dogs (188.68 +/- 85.24 ng . mL(-1) . h) or old dogs (1
20.49 +/- 22.03 ng . mL(-1) . h). L-NAME (5 mg . hg(-1) x 2 IV) suppressed
GH release induced by the peptide in young dogs (1,367.68 +/- 251.87 v 411.
12 +/- 68.49 ng . mL(-1) . h, P < .01), but potentiated it in old dogs (314
.73 +/- 117.10 v 1,103.97 +/- 374.11 ng . mL(-1) . h, P < .01). D-NAME (5 m
g . kg(-1) x 2 IV) did not affect the GH response to Hexarelin in either yo
ung (1,328.68 +/- 433.54 ng . mL(-1) . h) or aged (342.32 +/- 84.82 ng . mL
(-1) . h) dogs. Indomethacin (1.5 mg . kg(-1) IM) abolished the NO-donor po
tentiation of the GH response induced by Hexerelin in both young dogs (1,62
7.25 +/- 260.90 v 1,163.37 +/- 334.84 ng . mL(-1) . h, P < .05) and old dog
s (1,061.47 +/- 210.38 v 365.69 +/- 79.27 ng . mL(-1) . h, P < .01) without
affecting the plasma GH peak evoked by the peptide alone (young dogs, 786.
04 +/- 153.44 v 960.04 +/- 444.44 ng . mL(-1) . h, P = NS; old dogs, 474.55
+/- 47.30 v 490.82 +/- 144.86 ng . mL(-1) . h, P = NS). In conclusion, (1)
NO donors are capable to further increase the strong GH-releasing activity
of Hexarelin in both young and old dogs, although the site(s) and mechanis
m(s) of action of NO is still obscure; (2) the different GH response to the
peptide after NOS inhibition in young and old dogs signifies in the latter
an alteration of the somatotrope function; and (3) prostaglandins are the
downstream effecters of the chain of events triggered by activation of the
NO-ergic system. Copyright (C) 1999 by W.B. Saunders Company.